Skip to content
Parker Institute for Cancer Immunotherapy
Search
Search Close

Dana-Farber Cancer Institute

For 70 years, Dana-Farber has been on the frontlines of cancer research and the growing area of immunotherapy

Dana-Farber Cancer Institute boasts an impressive history of key discoveries about the immune system. Their powerhouse investigators have been on the frontlines. Dana-Farber’s research revealed that a protein known as PD-L1 is expressed on normal and cancer cells, enabling cancers to evade the immune response, and that blocking PD-L1 and a related protein, PD-1, could unleash the immune attack on tumor cells. PICI scientists at Dana-Farber are leaders in immunology and contribute greatly to our research agenda.

Elizabeth A. Mittendorf, MD, PhD | Co-Director
F. Stephen Hodi, MD | Co-Director
Kai W. Wucherpfennig, MD, PhD | Co-Director